PER-035-03已完成未知
RANDOMIZED MULTICENTRIC, DOUBLE-BLIND STUDY OF THE EFFECTIVENESS AND TOLERANCE OF DEXECADOTRIL VS. RACECADOTRIL, IN THE TREATMENT OF AQUEOUS WATER DIARRHEA IN CHILDREN.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- BIOPROJET,
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •- male patient older than 1 month and younger than 3 years,
- •- suffering from acute diarrhea, of presumed infectious origin, defined as a sudden increase in the number of stools characterized by the following 3 mandatory criteria:
- •* at least 3 or more watery or loose stools within the last 24 hours,
- •* Duration of diarrhea (from first diarrheal stool): at least 24 hours and not
- •more than 72 hours until the moment of inclusion
- •* the child requires hospitalization
- •- written informed consent of the parents.
排除标准
- •- previous episode of diarrhea within the last 2 weeks.
- •- presence of blood in the stools.
- •- the patient has received treatment with an antibiotic at therapeutic or acid doses acetylsalicylic, or some anti-diarrheic, within 72 hours before its inclusion.
- •- Severe malnutrition defined as a weight index for height less than 70% of the average NCSH,
- •- presence of any other disease or condition that requires antibiotic therapy at the time of its inclusion.
- •- Severe dehydration requiring intravenous rehydration.
- •- Known hypersensitivity to racecadotril.
- •- concomitant disease that may interfere with the study.
- •- patients participating in another study, or who have participated in another study the previous month, or have already participated in this study.
研究者
相似试验
进行中（未招募）
不适用
RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF THE EFFICACY, TOLERABILITY AND SAFETY OF VALDECOXIB (BEXTRA®)10 MG OD VS. DICLOFENAC SODIUM 50 MG TDS FOR 6 WEEKS IN SUBJECTS WITH OSTEOARTHRITIS OF THE KNEE. - N/AOsteoarthritis of the kneeClassification code 10031161EUCTR2004-001713-34-GBPfizer Limited516
已完成
不适用
A RANDOMIZED, DOUBLE-BLIND, MULTICENTRIC STUDY TO EVALUATE THE TOLERABILITY AND EFFECTIVENESS OF 90 MG ETORICOXIB ONCE A DAY COMPARED WITH 75 MG SODIUM DICLOFENACO TWICE A DAY IN PATIENTS WITH RHEUMATOID ARTHRITIS.-M06M06PER-011-03MERCK & CO.INC.,
已完成
不适用
A RANDOMIZED, DOUBLE-BLIND, MULTICENTRIC STUDY TO EVALUATE THE TOLERABILITY AND EFFECTIVENESS OF ETORICOXIB 90 MG PER DAY, VS. SODIC DICLOFENACO 50 MG THREE TIMES A DAY IN PATIENTS WITH OSTEOARTHRITIS.-M15M15PER-054-02MERCK SHARP & DOHME PERU S.R.L.,
已完成
不适用
A RANDOMIZED, DOUBLE-BLIND, MULTICENTRIC STUDY OF ZOLEDRONIC ACID (4 MG AND 8 MG) ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH RECIDIVAL OR REFRACTORY HYPERCALCEMIA, INDUCED BY NEOPLASIA.-E835 Disorders of calcium metabolismDisorders of calcium metabolismE835PER-062-02OVARTIS BIOSCIENSES PERU S.A.,
已完成
不适用
MULTICENTRIC, RANDOMIZED, DOUBLE-BLIND STUDY, IN PARALLEL GROUPS, WITH ACTIVE CONTROL, OF 24 WEEKS OF DURATION, TO EVALUATE THE EFFICACY OF THE COMBINATION VALSARTAN / HYDROCHLOROTHYAZIDE VERSUS AMLODIPINE ON THE SYSTOLIC ARTERIAL PRESSURE IN PATIENTS WITH MODERATE HYPERTENSION WITH RISK FACTORS AND / OR CARDIOVASCULAR CONCOMYANT DISEASE-I10 Essential (primary) hypertensionEssential (primary) hypertensionI10PER-010-03OVARTIS BIOSCIENSES PERU S.A.,